|
⚲
|
| Keyboard |
| Jay Flatley | |
|---|---|
| Firm | |
| Address | c/o Denali Therapeutics Inc 161 Oyster Point Blvd South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Denali Therapeutics Inc | 021-506551 | Director | 499.7 M of 499.7 M |
||
| Cellanome Inc | 021-503792 | Director | 150.0 M of 150.0 M |
||
| Cellanome Inc | 021-454964 | Director | 40.7 M of 40.7 M |
||
| Iridia Inc | 021-421246 | Director | 6.0 M of 6.0 M |
||
| Iridia Inc | 021-380645 | Director | 18.0 M of 18.0 M |
||
| Iridia Inc | 021-336811 | Director | 3.5 M of 3.5 M |
||
| Iridia Inc | 021-314317 | Director | 2.0 M of 2.5 M |
||
| Juno Therapeutics Inc | 021-296114 | Director | 31.1 M of 31.1 M |
||
| Helix Holdings I LLC | 021-244640 | Director | 185.0 M of 185.0 M |
||
| Juno Therapeutics Inc | 021-243722 | Director | 898.5 M | ||
| Genvault Corp | 021-54107 | Director | 6.8 M of 6.8 M |
||
| Helixis Inc | 021-109432 | Director | 7.3 M of 10.0 M |
||